new warnings about complications from severe diarrhea in patients taking Zelnorm (tegaserod)

You'll see new warnings about complications from severe diarrhea in patients taking Zelnorm (tegaserod).

Health Canada will work with Novartis on new wording for the monograph.

This is not a surprise.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote